Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0721
Source ID: NCT00358046
Associated Drug: Ily101
Title: Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Kidney Diseases|Renal Insufficiency
Interventions: DRUG: ILY101
Outcome Measures:
Sponsor/Collaborators: Sponsor: Ilypsa
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 120
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT
Start Date: 2006-06
Completion Date:
Results First Posted:
Last Update Posted: 2007-02-07
Locations: Clinical Study Site, Mobile, Alabama, United States|Clinical Study Site, Mountain View, California, United States|Clinical Study Site, Riverside, California, United States|Clinical Study Site, San Diego, California, United States|Clinical Study Site, Thornton, Colorado, United States|Clinical Study Site, Ocala, Florida, United States|Clinical Study Site, Palm Beach Gardens, Florida, United States|Clinical Study Site, Pembroke Pines, Florida, United States|Clinical Study Site, Des Moines, Iowa, United States|Clinical Study Site, Baton Rouge, Louisiana, United States|Clinical Study Site, Rochester, New York, United States|Clinical Study Site, Allentown, Pennsylvania, United States|Clinical Study Site, Houston, Texas, United States|Clinical Study Site, San Antonio, Texas, United States|Clinical Study Site, Provo, Utah, United States|Clinical Study Site, Salt Lake City, Utah, United States|Clinical Study Site, Norfolk, Virginia, United States|Clinical Study Site, Appleton, Wisconsin, 54911, United States
URL: https://clinicaltrials.gov/show/NCT00358046

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress